William Blair Issues Positive Outlook for Celsius Earnings

Key Points

• William Blair raised its Q3 2025 earnings per share estimate for Celsius from $0.19 to $0.20, reflecting positive growth expectations for the company.
• Celsius reported a significant increase in Q3 earnings, with $0.47 earnings per share that exceeded the consensus estimate by $0.24 and an impressive 83.9% revenue growth year-over-year.
• Several brokerages upgraded their price targets for Celsius, with Citigroup and UBS Group boosting ratings to "buy" and setting targets as high as $64.00.

Celsius Holdings Inc. (NASDAQ:CELH - Free Report) - William Blair boosted their Q3 2025 earnings per share estimates for shares of Celsius in a report released on Thursday, August 7th. William Blair analyst J. Andersen now anticipates that the company will earn $0.20 per share for the quarter, up from their previous estimate of $0.19. The consensus estimate for Celsius' current full-year earnings is $0.89 per share. William Blair also issued estimates for Celsius' Q4 2025 earnings at $0.17 EPS.

Celsius (NASDAQ:CELH - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The company reported $0.47 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.23 by $0.24. Celsius had a return on equity of 36.88% and a net margin of 7.91%. The firm had revenue of $739.30 million for the quarter, compared to analysts' expectations of $632.13 million. During the same period last year, the business posted $0.28 earnings per share. The firm's revenue for the quarter was up 83.9% on a year-over-year basis.

Several other brokerages have also recently issued reports on CELH. Bank of America raised their price objective on Celsius from $35.00 to $40.00 and gave the stock an "underperform" rating in a research note on Friday. JPMorgan Chase & Co. raised their price objective on Celsius from $44.00 to $54.00 and gave the stock an "overweight" rating in a research note on Thursday, July 31st. Needham & Company LLC restated a "buy" rating and set a $60.00 price objective (up from $55.00) on shares of Celsius in a research note on Thursday. Citigroup raised their price objective on Celsius from $55.00 to $60.00 and gave the stock a "buy" rating in a research note on Friday. Finally, UBS Group raised their price objective on Celsius from $57.00 to $64.00 and gave the stock a "buy" rating in a research note on Friday. One analyst has rated the stock with a sell rating, three have given a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $51.72.

Celsius Stock Performance

Shares of CELH opened at $51.95 on Monday. The business's fifty day moving average price is $44.51 and its 200 day moving average price is $36.21. Celsius has a 12-month low of $21.10 and a 12-month high of $53.85. The stock has a market capitalization of $13.39 billion, a PE ratio of 140.41, a price-to-earnings-growth ratio of 1.80 and a beta of 1.40. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.11 and a quick ratio of 1.76.

Hedge Funds Weigh In On Celsius

Institutional investors have recently bought and sold shares of the stock. Triumph Capital Management increased its stake in Celsius by 41.5% in the 4th quarter. Triumph Capital Management now owns 40,420 shares of the company's stock worth $1,065,000 after purchasing an additional 11,863 shares in the last quarter. Fifth Third Bancorp grew its stake in Celsius by 62.9% during the 1st quarter. Fifth Third Bancorp now owns 1,725 shares of the company's stock valued at $61,000 after acquiring an additional 666 shares in the last quarter. GAMMA Investing LLC grew its stake in Celsius by 4,164.4% during the 1st quarter. GAMMA Investing LLC now owns 73,092 shares of the company's stock valued at $2,604,000 after acquiring an additional 71,378 shares in the last quarter. Oppenheimer & Co. Inc. grew its stake in Celsius by 14.0% during the 1st quarter. Oppenheimer & Co. Inc. now owns 9,760 shares of the company's stock valued at $348,000 after acquiring an additional 1,199 shares in the last quarter. Finally, Cambridge Investment Research Advisors Inc. grew its stake in Celsius by 21.4% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 45,517 shares of the company's stock valued at $1,621,000 after acquiring an additional 8,009 shares in the last quarter. Hedge funds and other institutional investors own 60.95% of the company's stock.

Insider Activity

In other news, CEO John Fieldly sold 143,167 shares of the firm's stock in a transaction on Thursday, August 7th. The stock was sold at an average price of $51.18, for a total transaction of $7,327,287.06. Following the transaction, the chief executive officer directly owned 895,410 shares of the company's stock, valued at approximately $45,827,083.80. This trade represents a 13.78% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, major shareholder William H. Milmoe sold 300,000 shares of Celsius stock in a transaction dated Tuesday, July 1st. The stock was sold at an average price of $47.27, for a total value of $14,181,000.00. Following the transaction, the insider directly owned 18,017,770 shares in the company, valued at approximately $851,699,987.90. The trade was a 1.64% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 1,106,141 shares of company stock valued at $51,985,705. Company insiders own 2.20% of the company's stock.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.